Meanwhile, ACTN4 is also involved in the progression of several diseases, including melanoma, hepatocellular carcinoma, nasopharyngeal carcinoma, and ovarian clear-cell adenocarcinomas [14–17]. This evidence concerns the gene ACTN4 and nasopharyngeal carcinoma.